News
Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study
Abstract Objectives This study aimed to provide long-term clinical data about an innovative epidermal radioisotope therapy called Rhenium-SCT® (Skin…
China Isotope & Radiation Corporation (CIRC) and OncoBeta sign distribution agreement for Tungsten 188/Rhenium-188 generators
Beijing, China and Garching near Munich, Germany, Tuesday 30th June 2020. CIRC and OncoBeta today announced that they have signed an agreement for the…
How can you Reduce the Risk of Skin Cancer?
Skin Cancer is the most common type of cancer in the world 1. Ultraviolet (UV) Radiation exposure is one of the major causes of melanoma and…
COVID-19: We are here for you.
To our Valued Patients, Customers and Health Care providers, As we navigate through these trying times surrounding the Coronavirus (COVID-19)…
B.J. Madan & Co India and OncoBeta announce exclusive distribution agreement for W/Re-188 generators.
New Delhi, India and Garching near Munich, Germany, 6th March, 2020. B.J Madan & Co and OncoBeta announced the execution of an exclusive distribution…
RadioMedix and OncoBeta announce exclusive distribution agreement for W/Re-188 generators in U.S. and Canada.
RadioMedix and OncoBeta today announced the execution of an exclusive distribution agreement for the next generation of W/Re-188 generators in the…
Oncobeta chosen as one of the Trailblazing Companies to Watch in 2019
OncoBeta- A Pioneer And Innovator In The Epidermal Radioisotope Therapy Sector Skin is the largest organ of the body and represents the first barrier…
OncoBeta® receives Corporate Excellence Award 2019
OncoBeta recognized as the Most Compassionate Skin Cancer Therapy Provider in 2019.
OncoBeta®, a Medical Device Company specialized in innovative…
First non-melanoma skin cancer patients treated with the Rhenium-SCT® in Germany
The first Rhenium-SCT® treatment was accomplished by the interregional professional association for nuclear medicine in Hanau
Dr. Lutz-Hendrik…
OncoBeta® chosen as a 2019 Red Herring Top 100 Europe Winner
OncoBeta® GmbH, a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs),…